Search

Objective To explore the application effect of ultrasound-assisted vascular classification management in therapeutic apheresis (TA) patients.Methods A total of 174 patients undergoing TA in the Department of Hematology of a tertiary hospital in Xiamen from January 2019 to November 2023 were selected as the study subjects.According to the treatment time, they were divided into an observation group (January 2022 to November 2023) and a control group (January 2019 to December 2021), with 87 patients in each group.The control group had venous access placed by the TA team based on personal experience, while the observation group underwent vascular classification management assisted by B-mode ultrasound.The differences between the two groups were compared in terms of one-time puncture success rate, central venous catheter (CVC) usage rate, venous catheter complications, apheresis-related adverse reactions, venous catheter costs, and patient satisfaction.Results Both groups completed the TA.The one-time puncture success rate in the observation group was 93.1%, which was significantly higher than the 81.6% in the control group (P＜0.05). The CVC insertion rate and associated costs in the observation group were lower than those in the control group, and patient satisfaction in the observation group was higher than that in the control group, with statistically significant differences (P＜0.05). Venous catheter complications in both groups were related to CVC, but there was no statistically significant difference in the incidence rate (P＞0.05). Conclusion Ultrasound-assisted vascular classification management can improve the one-time catheterization success rate and patient satisfaction in TA patients, while reducing the CVC insertion rate and associated costs. [ABSTRACT FROM AUTHOR]

In order to clarify the sensitivity of Coniella vitis to mefentrifluconazole, the sensitivity of 66 C. vitis isolates from 6 cities in Shandong Province to mefentrifluconazole was determined by the mycelial growth rate method. Additionally, the indoor and field control efficacy of mefentrifluconazole and three triazole fungicides, propiconazole, difenoconazole, and tebuconazole was compared. The results showed the population of C. vitis exhibited sensitivity to mefentrifluconazole, with effective inhibition concentrations (EC50) ranging from 0.0210 to 1.9464 μg/mL and an average value of (0.7578 ± 0.4322) μg/mL. The sensitivity frequency is distributed in a continuous unimodal curve, conforming to a normal distribution. Therefore, the average EC50 value can be considered as the baseline sensitivity of C. vitis in Shandong Province to mefentrifluconazole. The average EC50 values of propiconazole, difenoconazole and tebuconazole against 31 randomly selected isolates were (1.1667 ± 0.4456), (2.1577 ± 0.5007) and (5.8187 ± 1.5538) μg/mL, respectively. The experiments showed the activity of mefentrifluconazole against C. vitis was comparable to that of propiconazole and difenoconazole, and better than that of tebuconazole. These findings provide a basis for monitoring pesticide resistance and effective control of C. vitis in fields. [ABSTRACT FROM AUTHOR]

Copyright of Journal of Anhui Agricultural Sciences is the property of Journal of Anhui Agricultural Sciences Editorial Office and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Copyright of Acta Agronomica Sinica is the property of Crop Science Society of China and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Copyright of Journal of Food Safety & Quality is the property of Journal of Food Safety & Quality Editorial Department and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Copyright of Shipin Kexue/ Food Science is the property of Food Science Editorial Department and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Copyright of Chinese Journal of Pesticide Science / Nongyaoxue Xuebao is the property of Chinese Journal of Pesticide Science and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

目的观察盐酸羟考酮缓释片和盐酸吗啡缓释片在癌症患者疼痛治疗中的疗效与不良反应的差异。方法回顾性分析该院肿瘤内科2012年2月至2016年6月收治的306例癌症患者,观察使用盐酸羟考酮缓释片或盐酸吗啡缓释片止痛的疗效和不良反应情况。结果使用盐酸吗啡缓释片的125例患者中,改用盐酸羟考酮缓释片后有27例(21.6%)患者止痛效果不佳。使用盐酸羟考酮缓释片的181例患者中,有10例(5.5%)患者改用盐酸吗啡缓释片止痛效果不佳。盐酸吗啡缓释片的“前庭病”、呕吐和便秘发生率显著高于盐酸羟考酮缓释片,差异有统计学意义(P<0.05)。结论(1)对于不同患者,盐酸羟考酮缓释片或盐酸吗啡缓释片的止痛效果不同。(2)盐酸吗啡缓释片的不良反应发生率显著高于盐酸羟考酮缓释片。在使用盐酸吗啡缓释片或盐酸羟考酮缓释片治疗癌症患者慢性疼痛的过程中,当其中某一个药物止痛效果下降时,与增加原来药物的剂量相比,更换另一个药物可能是更好的选择。 [ABSTRACT FROM AUTHOR]